Annual Total Liabilities
$1.18 B
-$65.60 M-5.26%
December 31, 2023
Summary
- As of February 22, 2025, UTHR annual total liabilities is $1.18 billion, with the most recent change of -$65.60 million (-5.26%) on December 31, 2023.
- During the last 3 years, UTHR annual total liabilities has fallen by -$37.60 million (-3.08%).
- UTHR annual total liabilities is now -5.26% below its all-time high of $1.25 billion, reached on December 31, 2022.
Performance
UTHR Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$1.02 B
-$3.80 M-0.37%
September 30, 2024
Summary
- As of February 22, 2025, UTHR quarterly total liabilities is $1.02 billion, with the most recent change of -$3.80 million (-0.37%) on September 30, 2024.
- Over the past year, UTHR quarterly total liabilities has dropped by -$289.30 million (-22.06%).
- UTHR quarterly total liabilities is now -26.38% below its all-time high of $1.39 billion, reached on March 31, 2019.
Performance
UTHR Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
UTHR Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.3% | -22.1% |
| 3 y3 years | -3.1% | -22.1% |
| 5 y5 years | +99.3% | -5.1% |
UTHR Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -5.3% | at low | -22.1% | at low |
| 5 y | 5-year | -5.3% | +4.3% | -22.1% | at low |
| alltime | all time | -5.3% | >+9999.0% | -26.4% | >+9999.0% |
United Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.02 B(-0.4%) |
| Jun 2024 | - | $1.03 B(-11.3%) |
| Mar 2024 | - | $1.16 B(-2.1%) |
| Dec 2023 | $1.18 B(-5.3%) | $1.18 B(-9.9%) |
| Sep 2023 | - | $1.31 B(+3.2%) |
| Jun 2023 | - | $1.27 B(+3.9%) |
| Mar 2023 | - | $1.22 B(-2.0%) |
| Dec 2022 | $1.25 B(+3.1%) | $1.25 B(+2.3%) |
| Sep 2022 | - | $1.22 B(-0.4%) |
| Jun 2022 | - | $1.22 B(+3.5%) |
| Mar 2022 | - | $1.18 B(-2.2%) |
| Dec 2021 | $1.21 B(-0.8%) | $1.21 B(-0.7%) |
| Sep 2021 | - | $1.22 B(+1.1%) |
| Jun 2021 | - | $1.21 B(+0.8%) |
| Mar 2021 | - | $1.20 B(-2.0%) |
| Dec 2020 | $1.22 B(+7.7%) | $1.22 B(+8.1%) |
| Sep 2020 | - | $1.13 B(+0.2%) |
| Jun 2020 | - | $1.13 B(+4.5%) |
| Mar 2020 | - | $1.08 B(-4.9%) |
| Dec 2019 | $1.13 B(+91.0%) | $1.13 B(-11.7%) |
| Sep 2019 | - | $1.28 B(-3.6%) |
| Jun 2019 | - | $1.33 B(-4.1%) |
| Mar 2019 | - | $1.39 B(+134.1%) |
| Dec 2018 | $593.20 M(-21.8%) | $593.20 M(-15.3%) |
| Sep 2018 | - | $700.10 M(+6.1%) |
| Jun 2018 | - | $660.10 M(+4.5%) |
| Mar 2018 | - | $631.60 M(-16.7%) |
| Dec 2017 | $758.40 M(+63.7%) | $758.40 M(-10.4%) |
| Sep 2017 | - | $846.90 M(-5.5%) |
| Jun 2017 | - | $896.20 M(+84.7%) |
| Mar 2017 | - | $485.10 M(+4.7%) |
| Dec 2016 | $463.40 M(-20.7%) | $463.40 M(+10.4%) |
| Sep 2016 | - | $419.60 M(+9.2%) |
| Jun 2016 | - | $384.40 M(-18.1%) |
| Mar 2016 | - | $469.30 M(-19.7%) |
| Dec 2015 | $584.70 M(-5.5%) | $584.70 M(-14.0%) |
| Sep 2015 | - | $679.86 M(-0.5%) |
| Jun 2015 | - | $683.26 M(-12.7%) |
| Mar 2015 | - | $782.56 M(+26.5%) |
| Dec 2014 | $618.84 M(-21.0%) | $618.84 M(-27.7%) |
| Sep 2014 | - | $855.49 M(+15.6%) |
| Jun 2014 | - | $739.80 M(-2.3%) |
| Mar 2014 | - | $757.24 M(-3.3%) |
| Dec 2013 | $783.26 M(+47.3%) | $783.26 M(+26.4%) |
| Sep 2013 | - | $619.54 M(+10.3%) |
| Jun 2013 | - | $561.53 M(+4.8%) |
| Mar 2013 | - | $535.77 M(+0.8%) |
| Dec 2012 | $531.73 M(-4.8%) | $531.73 M(-9.4%) |
| Sep 2012 | - | $586.66 M(+7.3%) |
| Jun 2012 | - | $546.80 M(+1.9%) |
| Mar 2012 | - | $536.79 M(-3.9%) |
| Dec 2011 | $558.71 M | $558.71 M(-4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2011 | - | $582.08 M(+1.0%) |
| Jun 2011 | - | $576.40 M(+2.7%) |
| Mar 2011 | - | $561.20 M(+2.5%) |
| Dec 2010 | $547.75 M(+37.4%) | $547.75 M(+23.9%) |
| Sep 2010 | - | $442.05 M(+9.0%) |
| Jun 2010 | - | $405.37 M(+1.7%) |
| Mar 2010 | - | $398.45 M(-0.0%) |
| Dec 2009 | $398.54 M(+24.9%) | $398.54 M(+9.1%) |
| Sep 2009 | - | $365.17 M(+5.3%) |
| Jun 2009 | - | $346.69 M(+6.5%) |
| Mar 2009 | - | $325.53 M(+2.0%) |
| Dec 2008 | $319.20 M(+9.6%) | $319.20 M(-8.3%) |
| Sep 2008 | - | $348.09 M(+13.9%) |
| Jun 2008 | - | $305.53 M(-2.0%) |
| Mar 2008 | - | $311.63 M(+7.0%) |
| Dec 2007 | $291.23 M(+6.9%) | $291.23 M(-3.6%) |
| Sep 2007 | - | $302.18 M(+3.2%) |
| Jun 2007 | - | $292.79 M(+6.9%) |
| Mar 2007 | - | $273.91 M(+0.6%) |
| Dec 2006 | $272.37 M(+1569.8%) | $272.37 M(+1098.4%) |
| Sep 2006 | - | $22.73 M(-12.3%) |
| Jun 2006 | - | $25.91 M(+33.1%) |
| Mar 2006 | - | $19.46 M(+19.3%) |
| Dec 2005 | $16.31 M(+5.1%) | $16.31 M(-13.3%) |
| Sep 2005 | - | $18.82 M(+8.0%) |
| Jun 2005 | - | $17.43 M(+28.0%) |
| Mar 2005 | - | $13.62 M(-12.3%) |
| Dec 2004 | $15.52 M(+32.2%) | $15.52 M(-1.6%) |
| Sep 2004 | - | $15.77 M(+24.5%) |
| Jun 2004 | - | $12.66 M(+15.3%) |
| Mar 2004 | - | $10.99 M(-6.4%) |
| Dec 2003 | $11.74 M(-9.1%) | $11.74 M(-36.7%) |
| Sep 2003 | - | $18.54 M(+21.9%) |
| Jun 2003 | - | $15.20 M(+11.2%) |
| Mar 2003 | - | $13.67 M(+5.9%) |
| Dec 2002 | $12.91 M(-17.9%) | $12.91 M(-3.4%) |
| Sep 2002 | - | $13.36 M(-8.3%) |
| Jun 2002 | - | $14.57 M(+27.8%) |
| Mar 2002 | - | $11.40 M(-27.5%) |
| Dec 2001 | $15.72 M(-1.2%) | $15.72 M(+8.4%) |
| Sep 2001 | - | $14.51 M(-10.7%) |
| Jun 2001 | - | $16.25 M(+0.2%) |
| Mar 2001 | - | $16.21 M(+1.9%) |
| Dec 2000 | $15.91 M(+152.5%) | $15.91 M(+64.5%) |
| Sep 2000 | - | $9.67 M(+12.9%) |
| Jun 2000 | - | $8.56 M(+25.5%) |
| Mar 2000 | - | $6.82 M(+8.3%) |
| Dec 1999 | $6.30 M(+215.0%) | $6.30 M(+53.7%) |
| Sep 1999 | - | $4.10 M(+156.3%) |
| Jun 1999 | - | $1.60 M(-30.4%) |
| Mar 1999 | - | $2.30 M |
| Dec 1998 | $2.00 M | - |
FAQ
- What is United Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for United Therapeutics?
- What is United Therapeutics annual total liabilities year-on-year change?
- What is United Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for United Therapeutics?
- What is United Therapeutics quarterly total liabilities year-on-year change?
What is United Therapeutics annual total liabilities?
The current annual total liabilities of UTHR is $1.18 B
What is the all time high annual total liabilities for United Therapeutics?
United Therapeutics all-time high annual total liabilities is $1.25 B
What is United Therapeutics annual total liabilities year-on-year change?
Over the past year, UTHR annual total liabilities has changed by -$65.60 M (-5.26%)
What is United Therapeutics quarterly total liabilities?
The current quarterly total liabilities of UTHR is $1.02 B
What is the all time high quarterly total liabilities for United Therapeutics?
United Therapeutics all-time high quarterly total liabilities is $1.39 B
What is United Therapeutics quarterly total liabilities year-on-year change?
Over the past year, UTHR quarterly total liabilities has changed by -$289.30 M (-22.06%)